Sino Biopharmaceutical Ltd (SBMFF)
0.3538
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
Sino Biopharmaceutical Market Cap: 6.649B for June 21, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
June 21, 2024 | 6.649B |
June 20, 2024 | 6.649B |
June 18, 2024 | 6.649B |
June 17, 2024 | 6.649B |
June 14, 2024 | 6.649B |
June 13, 2024 | 6.649B |
June 12, 2024 | 6.649B |
June 11, 2024 | 6.953B |
June 10, 2024 | 6.953B |
June 07, 2024 | 6.953B |
June 06, 2024 | 6.953B |
June 05, 2024 | 6.953B |
June 04, 2024 | 6.868B |
June 03, 2024 | 6.868B |
May 31, 2024 | 6.868B |
May 30, 2024 | 5.918B |
May 29, 2024 | 5.918B |
May 28, 2024 | 5.918B |
May 24, 2024 | 5.918B |
May 23, 2024 | 5.918B |
May 22, 2024 | 5.918B |
May 21, 2024 | 5.918B |
May 20, 2024 | 5.918B |
May 17, 2024 | 5.918B |
May 16, 2024 | 5.918B |
Date | Value |
---|---|
May 15, 2024 | 5.918B |
May 14, 2024 | 5.918B |
May 13, 2024 | 5.918B |
May 10, 2024 | 5.918B |
May 09, 2024 | 5.918B |
May 08, 2024 | 5.918B |
May 07, 2024 | 5.918B |
May 06, 2024 | 5.918B |
May 03, 2024 | 5.918B |
May 02, 2024 | 5.918B |
May 01, 2024 | 5.918B |
April 30, 2024 | 5.918B |
April 29, 2024 | 5.918B |
April 26, 2024 | 5.918B |
April 25, 2024 | 5.918B |
April 24, 2024 | 5.918B |
April 23, 2024 | 5.918B |
April 22, 2024 | 5.918B |
April 19, 2024 | 5.918B |
April 18, 2024 | 6.567B |
April 17, 2024 | 7.197B |
April 16, 2024 | 7.197B |
April 15, 2024 | 7.197B |
April 12, 2024 | 7.197B |
April 11, 2024 | 6.882B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.918B
Minimum
Apr 19 2024
28.31B
Maximum
Jul 20 2020
13.68B
Average
13.16B
Median
Market Cap Benchmarks
Global Pharmatech Inc | 8.265M |
HUTCHMED (China) Ltd | 3.061B |
Pharmaron Beijing Co Ltd | 2.493B |
Regencell Bioscience Holdings Ltd | 52.05M |
Prenetics Global Ltd | 73.30M |
Market Cap Related Metrics
PE Ratio | 19.94 |
PS Ratio | 1.778 |
Price to Book Value | 1.547 |
Price to Free Cash Flow | 10.72 |
Price | 0.3538 |
Earnings Yield | 5.02% |
Operating PE Ratio | 8.050 |
Normalized PE Ratio | 23.97 |